MDxHealth Q4 Revenues Bounce 89 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – MDxHealth today said that revenues in the fourth quarter increased 89 percent year over year, though its net loss widened.

For the three months ended Dec. 31, 2012, the molecular diagnostics firm took in €1.7 million ($2.2 million) in revenues, compared to €900,000 a year ago. MDxHealth attributed the improvement to its ClinicalMDx and PharmacoDx products and services, though it did not elaborate.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.